FDA to Review Birth Control Device Amid Growing Complaints
Federal regulators said they will hold a public meeting to “discuss scientific data regarding Essure’s safety and effectiveness,” a review that comes after the I-Team uncovered inconsistencies in a clinical trial survey used to win FDA approval for the birth control device.